Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Modern hair restoration techniques can effectively treat hair loss and provide natural-looking results.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Wound healing is complex and requires more research to enhance treatment methods.

New treatments for skin and hair repair show promise, but further improvements are needed.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Eating a balanced diet with the right vitamins and minerals is important for healthy hair, but too many supplements can be harmful.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Hairless protein is key for hair growth, cell differences cause gene expression variation, and the N-end rule pathway senses nitric oxide for protein breakdown.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Cyclosporin doesn't stop hair loss.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Prostanoids, like prostaglandins and thromboxane A2, can both enhance and inhibit hair growth, and understanding their effects could help treat hair disorders.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Testosterone increases acidification in the vas deferens by up-regulating V-ATPase.